To promote the consistency evaluation of the quality and efficacy of generic drugs, and clarify the relationship between the registration standards of generic drugs and the national drug standards such as the Pharmacopoeia of the People's Republic of China, on August 2, 2019, NMPA issued theAnnouncement on Issues Pertaining to the Implementation of Drug Standards in the Consistency Evaluation of the Quality and Efficacy of Generic Drugs.